METiS TechBio

METiS is an innovative biotechnology company that leverages artificial intelligence (AI) to drive the development of more effective therapeutic drugs for patients through precise targeting drug delivery and drug discovery technologies. METiS aims to accelerate the research and development of innovative drugs more efficiently and accurately by integrating cutting-edge AI technology with traditional drug development, while also empowering the pharmaceutical ecosystem through its core technology platform to lead industry innovation. METiS was founded and is led by Dr. Hongmin Chen, a member of the U.S. National Academy of Engineering, along with Dr. Cai-Da Lai and Dr. Wen-Shou Wang, top scientists from MIT. The core team includes drug development experts from renowned pharmaceutical companies such as Novartis, Amgen, and Regeneron, as well as young talents in artificial intelligence and computational fields.